Literature DB >> 25592322

Role of eukaryotic translation initiation factor 3a in bleomycin-induced pulmonary fibrosis.

Xian-Wei Li1, Yue-Han Wu2, Xiao-Hui Li2, Dai Li3, Jie Du2, Chang-Ping Hu2, Yuan-Jian Li4.   

Abstract

Eukaryotic translation initiation factor 3a (eIF3a) is a multifunctional protein and plays an important role in regulation of cellular function including proliferation and differentiation. In the present study, we tested the function of eIF3a in pulmonary fibrosis. Pulmonary fibrosis was induced by intratracheal instillation of bleomycin (5mg/kg) in rats. Primary pulmonary fibroblasts were cultured for proliferation investigation by BrdU incorporation method and flow cytometry. The expression/level of eIF3a, TGF-β1, ERK1/2 and α-SMA were analyzed by ELISA, real-time PCR or western blot. Results showed that the expression of eIF3a was obviously increased in lungs of pulmonary fibrosis rats accompanied by up-regulation of α-SMA and collagens. In cultured pulmonary fibroblasts, application of exogenous TGF-β1 induced cell proliferation and differentiation concomitantly with up-regulation of eIF3a expression and ERK1/2 phosphorylation. The effects of TGF-β1-induced proliferation of fibroblasts and up-regulation of α-SMA were abolished by eIF3a siRNA. TGF-β1-induced eIF3a expression was reversed in the presence of PD98059, an inhibitor of ERK1/2. These findings suggest that eIF3a plays an important role in bleomycin-induced pulmonary fibrosis by regulating pulmonary fibroblasts׳ function, and up-regulation of eIF3a induced by TGF-β1 is mediated via the ERK1/2 pathway.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ERK1/2; Eukaryotic translation initiation factor 3a; Pulmonary fibroblasts; Pulmonary fibrosis; TGF-β(1)

Mesh:

Substances:

Year:  2015        PMID: 25592322     DOI: 10.1016/j.ejphar.2015.01.004

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats.

Authors:  Wen-Qun Li; Xiao-Hui Li; Jie Du; Wang Zhang; Dai Li; Xiao-Ming Xiong; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-06       Impact factor: 3.000

2.  Knockdown of elF3a inhibits collagen synthesis in renal fibroblasts via Inhibition of transforming growth factor-β1/Smad signaling pathway.

Authors:  Yun-Fang Zhang; Qi Wang; Jie Luo; Shen Yang; Jie-Lin Wang; Hong-Yan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  NF-κB Mediates Mesenchymal Transition, Remodeling, and Pulmonary Fibrosis in Response to Chronic Inflammation by Viral RNA Patterns.

Authors:  Bing Tian; Igor Patrikeev; Lorenzo Ochoa; Gracie Vargas; KarryAnne K Belanger; Julia Litvinov; Istvan Boldogh; Bill T Ameredes; Massoud Motamedi; Allan R Brasier
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

4.  Amelioration of Bleomycin-induced Pulmonary Fibrosis of Rats by an Aldose Reductase Inhibitor, Epalrestat.

Authors:  Xianwei Li; Yuanyuan Shen; Yining Lu; Jieren Yang
Journal:  Korean J Physiol Pharmacol       Date:  2015-08-20       Impact factor: 2.016

5.  Identification of Target Genes in Hypertension and Left Ventricular Remodeling.

Authors:  Bo Pang; Cong Hu; Guodong Wu; Yanli Zhang; Guangzhu Lin
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

6.  MicroRNA‑875‑5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a.

Authors:  Tianxiang Chen; Liankang Sun; Bowen Yao; Liang Wang; Yufeng Wang; Yongshen Niu; Runkun Liu; Huanye Mo; Zhikui Liu; Kangsheng Tu; Qingguang Liu
Journal:  Oncol Rep       Date:  2020-08-19       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.